End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.24 USD | -4.50% | -0.93% | -21.77% |
May. 06 | Sagimet Biosciences Names Thierry Chauche CFO | MT |
May. 06 | Sagimet Biosciences Inc. Announces Appointment of Thierry Chauche as Chief Financial Officer | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 135M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -115M | EV / Sales 2024 * | - |
Net cash position 2024 * | 142M | Net cash position 2025 * | 217M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.95
x | P/E ratio 2025 * |
-1.07
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.59% |
1 day | -4.50% | ||
1 week | -0.93% | ||
Current month | +8.72% | ||
1 month | -12.22% | ||
3 months | -42.86% | ||
6 months | +90.13% | ||
Current year | -21.77% |
Managers | Title | Age | Since |
---|---|---|---|
David Happel
CEO | Chief Executive Officer | 62 | 22-10-23 |
George Kemble
CHM | Chairman | 63 | 11-08-14 |
Elizabeth Rozek
CMP | Compliance Officer | 53 | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Beth Seidenberg
BRD | Director/Board Member | 67 | 07-03-31 |
Richard Rodgers
BRD | Director/Board Member | 57 | 15-02-28 |
Director/Board Member | 60 | 21-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 4.24 | -4.50% | 338,761 |
24-05-10 | 4.44 | -2.84% | 374,056 |
24-05-09 | 4.57 | +2.93% | 396,172 |
24-05-08 | 4.44 | +2.54% | 312,845 |
24-05-07 | 4.33 | +1.17% | 288,054 |
End-of-day quote Nasdaq, May 12, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.77% | 135M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- SGMT Stock